2020/04/07 by Ya‐Nan Ou, Junxia Zhu, Xiao‐He Hou +5 · 1 voice
Medicine · Neuroscience · #Alzheimer's disease research and treatments #Tryptophan and brain disorders #Neuroinflammation and Neurodegeneration Mechanisms
paper · doi:10.3233/jad-191337
openalex publication_date 2020/04/07 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/31
BACKGROUND: The role of infectious agents in the development of Alzheimer's disease (AD) has long been debated, however, uncertainties still persist. OBJECTIVE: We aimed to illuminate the associations between infectious agents and risk of AD comprehensively. METHODS: Studies examining the associations between AD and infectious agents were identified through a systematic search of PubMed, Embase, and Cochrane library. A random-effects meta-analysis was conducted. Publication bias was explored using funnel plot. RESULTS: Fifty-one studies were included in the systematic review, of which forty-seven studies with 108,723 participants and 4,039 AD cases were eligible for meta-analysis. Evidence based on case control studies demonstrated that Chlamydia pneumoniae [odds ratio (OR): 4.39, 95% CI = 1.81-10.67; I2 = 68%)], Human herpes virus-6 (OR: 3.97, 95% CI = 2.04-7.75; I2 = 0%, Epstein-Barr virus (OR:1.45, 95% CI = 1.00-2.08; I2 = 0%), Herpes simplex virus-1 (OR:1.34, 95% CI = 1.02-1.75; I2 = 0%), and the Herpesviridae family (OR:1.41, 95% CI = 1.15-1.74; I2 = 12%) infection were associated with a higher risk of AD. No significant evidence of publication bias was found. CONCLUSION: These findings strengthened the evidence that infection may play an important role in AD. Additional research is required to determine whether treatment strategies targeting infectious diseases to prevent AD are viable in the future.